Ann D. Rhoads - 26 Jan 2023 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Reporting relationship: Director
Issuer ticker: GMED
Reported as of: 26 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Feb 2023, 15:58:45 UTC
Prior SEC filing: 10 Jun 2022
Next SEC filing: 30 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Kelly G. Huller, Attorney-in-Fact

Key filing fact

Ann D. Rhoads filed Form 4 for GLOBUS MEDICAL INC (GMED) on 27 Feb 2023.

Key facts

This page summarizes Ann D. Rhoads's Form 4 filing for GLOBUS MEDICAL INC (GMED).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Feb 2023, 15:58.

Change

Previous filing in this sequence was filed on 10 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GMED transaction Derivative

Stock Option (Right to Buy Class A Common Stock)

Award

Transaction value: $0
Shares: +15,000
Change %
Price: $0.000000
Shares after: 15,000
Date: 26 Jan 2023
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 15,000
Exercise price: $75.18
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options were granted on January 26, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.